# ðŸ§¬ Biotech Go-to-market and Pipeline Growth
Repositioned a niche biotech solution as an enterprise-scale climate asset, accelerating enterprise deals and investor traction.

**Client:** Series B French biotech startup (insect-based protein, 60+ employees)  
**Objective:** Increase investor confidence and accelerate enterprise deal flow in a conservative, risk-sensitive market.

---

### 1. The Challenge
Enterprise buyers and late-stage investors hesitated due to **perceived category risk and scalability uncertainty**. The solution was seen as experimental rather than deployable at scale, and messaging across channels was inconsistent, slowing pipeline progression and investor engagement.

---

### 2. Strategy
**Enterprise Lead Acquisition & Account-Based Marketing (ABM)**

To address perceived category risk and demonstrate scalability, I designed a **multi-channel ABM strategy** targeting enterprise accounts and late-stage investors. Each touchpoint reinforced **climate impact, scalability, and alternative protein positioning** while keeping messaging consistent with audience expectations.

**Channels:**
* LinkedIn account targeting and credibility campaigns
* Segmented email sequences
* Webinars
* PR and partner outreach

**Tools:**
* HubSpot (CRM and lead qualification)
* Google Analytics 4 (GA4)
* ConvertKit
* GoToWebinar

**Methods:**
* ABM workflows
* Lead acquisition funnels
* A/B testing
* Performance optimization

---

### 3. Execution
* Built ABM workflows for investors, partners, and enterprise accounts  
* Created thought leadership assets: founder webinars, gated reports, case briefs  
* Launched LinkedIn credibility campaigns with tailored messaging  
* Led PR and partner outreach using a climate-scale narrative
* Built CRM dashboards to track attribution and pipeline velocity  

---

### ABM Pipeline Workflow (HubSpot)

<p align="center">
<em>Stages used for enterprise + investor ABM qualification and deal progression. Probabilities reflect conversion likelihood across the funnel.</em> 
<img src="abm_pipeline_screenshot.png" alt="HubSpot Pipeline Screenshot" />
</p>

---
### LinkedIn Sponsored Campaign

<div align="center">
<em>Example of LinkedIn sponsored content used in ABM campaigns targeting enterprise and investor accounts.</em><br>
<em>Logo and company name blurred for confidentiality.</em><br><br>
<img src="Biotech LinkedIn Sponsored Post Screenshot.png" alt="LinkedIn Sponsored Post Screenshot" />
</div>

**Purpose:** Build credibility and engagement with high-value accounts, highlighting climate-scale protein solution.

**Key Metrics:**
* **139 likes, 16 comments, 2 shares** on this post  
* **CTR:** ~5% across ABM campaign touchpoints  

> Note: Part of multi-channel ABM strategy integrating LinkedIn, email sequences, webinars, and PR/partner outreach to drive pipeline and qualified engagement.

--- 

### 4. Results & Impact

- **â‚¬5M+** in enterprise and investor pipeline generated in Q1â€“Q2
- **~25%** faster deal cycles driven by ABM workflows and climate-scale repositioning
- **60+ high-value accounts** engaged, segmented by sustainability mandate, funding readiness, and company size
- **3 strategic partnerships** advanced to proposal stage
- **Investor confidence increased**, securing meetings with 3 sustainability funds + 2 corporate VCs
- **Digital and content channels directly influenced late-stage pipeline movement,** with:
  - **~5% CTR** across ABM campaign touchpoints
  - **2,000+ content interactions** from reports, webinars and briefs
- **Full-funnel visibility maintained through HubSpot dashboards**, tracking attribution, velocity and stage conversion



---

### 5. Key Insight
The primary barrier was **market validation and positioning, not demand**. Reframing the solution as climate-scale infrastructure reduced perceived risk, accelerated enterprise deal flow and increased investor conviction.
